We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · December 23, 2020

Peritoneal Cancer Index–Based Patient-Selecting Strategy for Complete Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Metastasis

European Journal of Surgical Oncology

 

Additional Info

European Journal of Surgical Oncology
Peritoneal Cancer Index (PCI) Based Patient Selecting Strategy for Complete Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Metastasis: A Single-Center Retrospective Analysis of 125 Patients
Eur J Surg Oncol 2020 Dec 01;[EPub Ahead of Print], ZH Ji, Y Yu, G Liu, YB Zhang, SL An, B Li, XB Li, GJ Yan, Y Li

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading